Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

A male with aromatase deficiency improved bone health with estradiol treatment.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Follicle Stimulating Hormone is important for fertility.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

People with alopecia areata have higher insulin resistance.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

There is not enough evidence to support health claims about soy isoflavones.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Women with pattern hair loss often have higher blood sugar, cholesterol, blood pressure, and waist size, suggesting a link between hair loss and metabolic syndrome.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Vegetable protein lowers cholesterol and protein deficiency can cause health issues.

People with male pattern baldness are more likely to have metabolic syndrome.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.